Verona Pharma plc
USD106.91
+0.12 (+0.11%)
CEO
David S. Zaccardelli
IPO Date
2017-04-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
GB
Open
$106.91
Prev. Close
$106.79
Day Low
$106.91
Day High
$106.91
52W Low
$31.09
52W High
$106.93
Market Cap
$72.68B
Volume
1.87M
| -35.2 |
| 31 Dec 2022 | FY | 24.5% | -15000.2% | -24.7% | -21.9% | 0.05 | 12.77 | -30.4 |
| 31 Dec 2021 | FY | 100.0% | -138.9% | -27.8% | -22.0% | 0.04 | 5.09 | -9.7 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -25.8% | -23.3% | 0.03 | 14.26 | -4.8 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -94.9% | -51.7% | 0.03 | 4.26 | -1.9 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -31.4% | -21.1% | 0.00 | 5.52 | -5.0 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -25.7% | -16.9% | 0.00 | 13.69 | -4.9 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -11.8% | -8.8% | 0.00 | 4.03 | -9.1 |
| 31 Dec 2015 | FY | 0.0% | 0.0% | -137.9% | -68.4% | 0.00 | 2.07 | -3.1 |
| -106.7 |
| 31 Dec 2024 | Q4 | 94.4% | -92.3% | -13.2% | -5.7% | 0.60 | 10.63 | -33.0 |
| 30 Sept 2024 | Q3 | 90.3% | -763.9% | -24.6% | -8.4% | 1.72 | 13.03 | -18.2 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -33.3% | -12.9% | 0.73 | 8.61 | -5.6 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -9.1% | -7.1% | 0.18 | 18.40 | -15.8 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -4.4% | -3.6% | 0.21 | 33.33 | -30.2 |
| 30 Sept 2023 | Q3 | 0.0% | 0.0% | -4.6% | -4.1% | 0.08 | 30.68 | -27.0 |
| 30 Jun 2023 | Q2 | 0.0% | 0.0% | -2.5% | -2.3% | 0.07 | 26.29 | -60.4 |
| 31 Mar 2023 | Q1 | 0.0% | 0.0% | -4.9% | -4.2% | 0.07 | 11.57 | -28.7 |